Polyoma virus encodes a potent oncogene, the middle Tantigen (MT), that induces cell transformation by copying the actions of tyrosine kinase associated growth factor receptors. A crucial component of MT transformation is its ability to bind and stimulate the activity of src-family kinases. However, the mechanism by which this is achieved remains unclear. Tyrosine phosphorylation of MT by src-kinases then provides binding sites for SH2 and PTB domain containing molecules in a paradigm of receptor action. We present evidence here that the MT/src complex contains equi-molar amounts of PP2A, and that phosphatase activity may be required for the interaction of MT with both PP2A and the srcfamily. PP2A, then, is a necessary component of the MT-src complex. We also show that two motifs in the 185 to 210 region of MT, each consisting of a basic area followed by a serine or threonine, are essential for interaction with src-kinases, but not PP2A. The spacing between the serine or threonine and the basic sequence also appears to be important. Substituting a cysteine residue in place of Thr203 in MT has no aect on the binding of pp60 c-src , showing that these sites interact with src-kinases by a novel mechanism that does not require phosphorylation.
Introduction
Expression of the polyoma virus encoded middle Tantigen (MT) in established rodent ®broblasts alters the cell's properties to a fully transformed phenotype (Treisman et al., 1981) . MT does not appear to express any enzymatic activity of its own. Instead, it exerts its eects by interacting with, and altering the activities of, essential growth regulatory proteins in the host cell. It is now clear that MT transforms cells by stimulating many of the pathways used by tyrosine kinase associated growth factor receptors (Dilworth, 1995) , and so can be used to study receptor signalling. MT binds the regulatory, A, and catalytic, C, subunits of protein phosphatase 2A (PP2A) (Pallas et al., 1990; Walter et al., 1990) , and three members of the srcfamily of tyrosine kinases, pp60 c-src (Courtneidge and Smith, 1983) , pp62 c-yes (Kornbluth et al., 1987) , and pp59 c-fyn (Cheng et al., 1988; Horak et al., 1989; Kypta et al., 1988) . As a consequence, the kinase activity of pp60 c-src , and probably pp62 c-yes , is stimulated (Bolen et al., 1984; Courtneidge, 1985) . The activated kinase then phosphorylates tyrosines in MT itself, and these form binding sites for the SH2 domains of the phosphatidylinositol 3'OH kinase (PI3K) 85 kDa subunit (Courtneidge and Heber, 1987; Kaplan et al., 1987; Talmage et al., 1989; Yoakim et al., 1992) , the SH2 domain of PLC-g1 (Su et al., 1995) , and the PTB domain of Shc (Blaikie et al., 1997; Campbell et al., 1994; Dilworth et al., 1994) . These molecules are in turn phosphorylated on tyrosine residues, which stimulates, either directly or indirectly, PI3K (Gorga et al., 1990; Serunian et al., 1990) and PLC-g1 (Su et al., 1995) enzymatic activity. The phosphotyrosines in Shc form a binding site for the SH2 domain of the adapter molecule, Grb2 (Campbell et al., 1994; Dilworth et al., 1994) , which, through its SH3 domains, brings the guanine nucleotide exchange factor mSos into the MT complex. This re-location of mSos to a membrane site can be sucient to activate p21 ras and the MAP Kinase pathway (Aronheim et al., 1994; Schlessinger, 1993) . Disruption of any of these interactions abrogates cell transformation by MT. In addition, phosphorylated Ser257 in MT interacts with members of the 14-3-3 family of proteins (Cullere et al., 1998; Pallas et al., 1994) . This in¯uences the type of tumours induced in animals, but has little eect on transformation of cells in culture. The polypeptides bound to MT, and the regions of the molecule involved in each association, are summarized in Figure 1 .
Interaction of the src-family members with MT is a vital step in the transformation process, therefore. However, despite many studies, we still do not understand the molecular mechanism involved in this binding, or how src-family kinase activity is deregulated by the interaction. It is clear that association does not require the SH2 or SH3 domains of pp60 c-src at least (Dunant et al., 1996) , so this interaction represents a novel means of controlling src-family activity. All of the other known associations between MT and cellular proteins parallel the interactions normally occurring during mitogenic signal transduction. Therefore, it is highly likely that understanding the MT/src interaction will shed light on src-kinase activation by growth factor receptors.
Mutation and monoclonal antibody studies have shown that the N-terminal region of MT is involved in the interaction with src-family kinases (Campbell et al., 1995; Cook and Hassell, 1990; Dilworth, 1982; Dilworth and Horner, 1993; Eckhart, 1993, 1995; Kornbluth et al., 1990; Markland and Smith, 1987; Pallas et al., 1986) . This area also binds PP2A (Campbell et al., 1995; Eckhart, 1993, 1995; Pallas et al., 1990; Walter et al., 1990 ) (see Figure  1 ). All mutations that disrupt PP2A binding to MT also aect the MT/src association, indicating that these two interactions are closely related, though it is unclear how or why they are linked. Through biochemical analysis, we demonstrate here that the MT/src-family complex probably contains an equal molar quantity of PP2A, suggesting that PP2A is required for binding src-kinases. We also show that the phosphatase activity of PP2A may be required for MT to interact with both PP2A and pp60 c-src . Recently, we have de®ned another region of MT, amino acids 185 to 210, that is required for association with pp60 c-src , but not PP2A (Brewster et al., 1997; Dilworth and Horner, 1993) . This sequence lies either side of the splice point that generates the unique protein of MT (Figure 1) . We report here the use of site directed mutagenesis to identify the important features in the 185 to 210 sequence that are required for MT binding to src-family kinases, and suggest ways that PP2A could promote this interaction through dephosphorylation of this region.
Results and Discussion
Protein phosphatase 2A is required for src-kinase binding to MT Previous experiments have suggested that the interactions between MT and PP2A or src-family kinases are linked. Although we have isolated MT mutants that disrupt pp60 c-src association without aecting PP2A interaction (Brewster et al., 1997) , no mutant that binds src-family kinases, but not PP2A, has yet been discovered. To investigate the MT/PP2A/src-family interaction biochemically, we have isolated the MT/ src complex to determine the ratio of PP2A to srckinase associated with MT ( Figure 2 ). The MT associated with src-family kinase was isolated by an immunochemical technique that puri®ed just the MT/ src complex. To achieve this, we ®rst used a monoclonal antibody that interacts with the same site on MT as that recognized by pp60 c-src (Dilworth and Horner, 1993) to remove from a lysate the majority of MT without a src-family kinase bound, including free MT and that associated only with PP2A. We then immunoprecipitated the remaining MT from the depleted lysate using a monoclonal antibody that recognizes all forms of the polypeptide. This precipi- , and the src-family kinases tentatively identi®ed previously as pp62 c-yes (Ulug et al., 1992) , to the right tate contains, then, only the MT that is associated with a src-family kinase, and the presence of less PP2A than src-family kinase would suggest the existence of a MT/ src complex without PP2A. To determine the stoichiometry of components within this complex, MT expressing cells were metabolically labelled to equilibrium (36 h) with 35 S-methionine, the MT-src complex isolated and separated on SDS ± PAGE, and then autoradiographed. The resulting ®lm was analysed with a Bioimage gel analysis system to provide integrated band intensities, which were then corrected for the number of methionines present in each polypeptide, to derive the ratio of MT to each of the other species. The methionine contents used were 14 for PP2A.A (from the human a-species sequence), six for PP2A.C (rat), 11 for pp60 c-src (mouse), 14 for pp62 c-yes (mouse), and 17 for MT. It has been shown that only one src-family kinase member associates with each molecule of MT . Therefore, the amount of pp60 c-src (identi®ed with speci®c antibodies), and the src-family kinase that migrates slightly slower (probably pp62 c-yes on the basis of antibody recognition (Ulug et al., 1992) ), were added together. The experiment was performed a number of times, and with varying conditions, and a representative gel is shown in Figure 2 . Small variations between experiments were observed, but the ratio of MT:srcfamily kinase:PP2A.A:PP2A.C was on average 1 : 1 : 1 : 1. Occasionally, the amount of MT present appeared lower than the other components (probably due to the diculties in accurately observing and quantitating a somewhat diuse band; see lane 4 where the MT appears under-represented), or the quantity of PP2A slightly higher. However, on no occasion did we observe more src-like kinase than PP2A, or the ratio of any component approaching twice the others. If we assume there is only one form of complex in these lysates, the most likely interpretation is that the complex consists of one molecule each of MT, a srcfamily kinase, PP2A.A, and PP2A.C. This agrees well with the 200 ± 220 kDa size of the kinase active fraction of MT observed by sedimentation analysis (Courtneidge and Smith, 1983; Grussenmeyer et al., 1985; Walter et al., 1982) . This makes it unlikely that a complex between MT and a src-kinase exists without PP2A.
A role for the phosphatase activity of PP2A in forming the MT-src complex To determine whether the PP2A phosphatase action is required for MT to bind pp60 c-src , we treated MT expressing cells for 48 h with 5 nM okadaic acid, a potent, speci®c inhibitor of PP2A. The cells were then lysed and the amount of pp60 c-src and PP2A bound to MT determined by an immunoprecipitation/Western blot approach (Figure 3) . Clearly, inhibition of PP2A activity does reduce the amount of pp60 c-src bound to MT (Figure 3b ), and this is also indicated by a concomitant reduction in the transformed appearance of the treated cells (data not shown). However, the amount of PP2A associated with MT also decreases (Figure 3c) , suggesting that the phosphatase activity may be required for PP2A itself to interact with MT. Similar results were observed when okadaic acid was added for shorter times (5 ± 6 h), but in this case, higher concentrations (150 nM) were needed to rapidly inactivate PP2A activity. The results indicate again, therefore, that in the absence of PP2A MT does not bind pp60 c-src , but whether the phosphatase activity is involved remains unclear.
MT phosphorylation site mutants
We have previously shown that the MT region between amino acids 185 and 210 is required for binding pp60 c-src (Brewster et al., 1997) . As PP2A is required for the interaction between MT and src-family kinases to form, we next investigated whether any of the possible phosphorylation sites in the 185 to 210 region of MT are involved in the binding of pp60 c-src . The DNA sequences encoding each serine, threonine and tyrosine in this region were ®rst mutated to express either alanine or phenylalanine, respectively (Figure 4) . The resulting mutant MT plasmids were then transfected into the rat ®broblast cell line Rat2 to assay for foci inducing ability ( Figure 5 ). Mutation of residues 187, 189, 206, 207, and 209 had no observable eect on transformation eciency. Alteration of Thr203 to Ala (mutant 203A) reduced the foci forming capacity to around 5% of that induced by wild type MT ( Figure  5f ). Mutation of Ser195 to Ala (195A) induced slightly less foci than wild type MT in some experiments, but not others (Figure 5e ). As these two residues have a similar amino acid environment (see later), we next examined whether Ser195 and Thr203 function together by constructing a mutant that had both residues mutated to alanine. This species, 195A.203A, formed very few foci when expressed in Rat2 cells (Figure 5j ), considerably less than either mutant alone. These two sites probably function co-operatively, then, with Thr203 playing the major role. No other pairs of mutations tested showed any co-operative eect in foci assays (data not shown).
To investigate whether phosphorylation of these amino acids was required for src-family kinase binding to MT, we next mutated Thr203 to a cysteine residue, which resembles threonine chemically, but cannot be phosphorylated. Mutant 203C transforms as well as wild type MT (Figure 5o ) indicating that Thr203, at least, can function when unphosphorylated. It is sometimes possible to permanently mimic the eects of phosphorylation at a site by replacing the target amino acid with acidic residues (Cowley et al., 1994) .
To test whether phosphorylation at Ser195 and Thr203 in MT would inhibit src-kinase binding, we next individually substituted both amino acids with either glutamic or aspartic acid residues, to create mutants 195E, 195D, 203E, and 203D. These mutants were even less transforming than the alanine substitutions ( Figure  5b , panels k, l, m and n). In each case, substitution of either glutamic or aspartic acid had identical eects. These two sites can function in an unphosphorylated state, then, and phosphorylation at these positions may inhibit transformation.
The above mutants were then transfected into Rat2 ®broblasts with a selectable marker gene, and stable cell lines expressing each mutant MT isolated. Lysates were prepared, and the cellular proteins associated with each MT examined by an approach involving immunoprecipitation followed by Western blotting (Brewster et al., 1997) . Pp60 c-src binding to MT correlated well with the mutant protein's transforming capacity (Figure 6a , and data not shown), indicating that reduced transformation is caused by alterations in the capacity of MT to bind src-family kinases. As it is likely that binding to other src-family members occurs by a similar mechanism, only the binding to pp60 This accounts for the other bands seen migrating both faster and slower than pp60 c-src in a. In each experiment, both negative and positive controls were performed, and the exposures matched to give similar levels associated with wild type MT both subunits of PP2A to the same extent as wild type MT (data not shown).
Other MT residues needed for interaction with pp60 c-src
We next investigated whether the amino acids surrounding Ser195 and Thr203 of MT also have a role in binding src-family kinases. N-terminal to both amino acids is a stretch of basic residues. Both of these regions were altered to small, neutral species, to produce mutants 192AGG and 199GG (Figure 4) . In both cases, the resultant MT showed dramatically reduced, or no, foci inducing capacity in Rat2 ®broblasts (Figure 5q and s) . Next, an acidic region lying between Ser195 and Thr203 was examined. Altering this to neutral amino acids, mutant 196AA, had no eect on transforming activity (Figure 5r) . Between Thr203 and the N-terminal basic ArgArg sequence are two alanines. To determine whether this spacing is important, we next deleted these two residues, mutant 201D2. This altered MT exhibited no transforming activity, suggesting the distance between Thr203 and the N-terminal basic region is probably important for binding pp60 c-src . Finally, Nterminal to basic residues 192 to 194 is a proline residue. Mutating this to alanine (mutant 191A) had no eect on MT's transforming activity (Figure 5p ), but this was a small dierence when compared to wild type MT in the same experiment. Cell lines expressing each of these mutants were then isolated, and the proteins interacting with each MT characterized. Once again, the ability to transform paralleled the amount of pp60 c-src bound to the mutant MT (data not shown). The transforming capacity and ability to bind host proteins for all the above mutants are summarized in Table 1 .
As with all mutation work, it is still technically feasible that these mutants merely destabilize the structure of MT in this region, and this aects srckinase binding. However, the number of point mutations we have isolated, and the consistency of the results obtained, makes this unlikely. The site in MT required for interaction with src-family kinases is probably made up of two motifs, each consisting of a basic area followed by a serine or threonine residue in an unphosphorylated state, then. The spacing between these basic residues and the serine/threonine also appears to be important, the two alanines separating the ArgArg from Thr203 being essential.
We have determined that PP2A is needed in order for MT to bind pp60 c-src , so it is tempting now to speculate about the reasons why. The requirement for PP2A, and the observation that Ser195 and Thr203 function in an unphosphorylated state, could possibly be linked. PP2A, then, may promote pp60 c-src binding to MT by maintaining these two residues in an unphosphorylated form. The inference that phosphorylation of these two amino acids may inhibit pp60 c-src binding to MT suggests that a kinase could prevent src-kinase association with MT in the absence of the phosphatase. Ser195 in MT lies in a good consensus sequence for cAMP dependent protein kinase, and in vitro, cAMP dependent protein kinase can phosphorylate this region (unpublished observation). It has also been reported that high levels of cAMP can revert some transformed properties of MT expressing cells (Kamech et al., 1987) . However, so far we have found no evidence that Ser195 or Thr203 are phosphorylated in vivo, even in MT mutants that no longer bind PP2A (data not shown). We cannot rule out the possibility that phosphorylation only occurs at speci®c subcellular sites, however, which MT only has access to when bound to PP2A (Brewster et al., 1997) . In addition, most of our experiments have been conducted in Rat2 ®broblasts, and other events may occur in dierent cell types.
All of the previously identi®ed associations between MT and other signalling molecules are similar to the interactions occurring on activated tyrosine kinaseassociated growth factor receptors. This suggests that the so-far-unique mechanism of pp60 c-src regulation by MT described here will be found to occur during signal transduction under normal circumstances, and so be of general importance. An analogue of MT that regulates pp60 c-src activity in the cell is now being sought.
Materials and methods

Serial immunoprecipitations and Western blotting
Rat2 cells and a line derived by transfecting wild type MT into Rat2 cells, were metabolically labelled by incubating for 36 h in medium containing 25% the normal concentration of methionine, 10% foetal calf serum, and 1 mCi of [ 35 S]-methionine per 60 mm dish. The cells were then lysed as above and immunoprecipitated with either PAb 762 or PAb 758 covalently linked to proteinA-Sepharose as in (Schneider et al., 1982) . The reaction was allowed to continue for 90 min at 48C with constant mixing, and then the Sepharose isolated by brief centrifugation. The PAb 758-treated supernatant was removed and re-precipitated a further two times, then reacted with PAb 762 Sepharose. In each case, the isolated Sepharose was washed four times with TBS-N (150 mM NaCl; 50 mM TrisCl, pH 8.0; 0.05% Nonidet-P40, 0.2TIU aprotinin/ml), eluted with sample buer, and electrophoresed as in (Laemmli, 1970) . Radioactive proteins were then detected The MT mutants listed in Figure 2 are shown with their ability to form foci in Rat2 cells and to associate with a number of cellular proteins. Foci formation is expressed relative to wild type MT (++++ is 100%, 70%), protein association is expressed qualitatively, not quantitatively by autoradiography. Densitometry of the autoradiograph was performed using a Bioimage Gel Analysis system. Western blotting was performed as in (Brewster et al., 1997) using the antibodies detailed in the Figure legends . The anti-MT monoclonal used for Western blotting was PAb762, the anti-Shc polyclonal antibody was from Transduction Laboratories, the anti-pp60 c-src polyclonal sera from Aniti Research Laboratories, and the anti-PP2A sera a kind gift of Dr Emin Ulug. For each mutant, the amount of lysate used was adjusted to provide approximately equivalent amounts of MT.
Mutagenic procedures
All mutations were made to one of two plasmids. pEMT is vector pEMBL8 containing the BamHI-EcoRI fragment of polyoma virus lacking the MT intron. pUCMT consists of the same fragment of MT cloned into the vector pUC19. All plasmid preparations were isolated by Qiagen columns (Qiagen). DNA manipulations were achieved by standard techniques (Sambrook et al., 1989) .
Point mutants were generated in pUCMT using oligonucleotides containing the required mutation and the USE Mutagenesis kit (Pharmacia) according to the manufacturer's recommendations. A SphI-CelII restriction enzyme fragment containing the mutation was then isolated from the resulting DNA and used to replace the same segment excised from pEMT. The replaced region was then sequenced using a Fidelity plasmid sequencing kit (Oncor/Appligene) to con®rm the presence of the mutation and the absence of any other alterations.
Cell culture, foci assays, and cell line isolation All cell culture was carried out by standard methods using Dulbecco's Modi®ed Eagles Medium (DMEM) supplemented with 10% foetal calf serum, incubated at 378C and 10% CO 2 .
The ability to form foci was assayed on the Rat2 cell line. Barely sub-con¯uent cells on 90 mm petri dishes were transfected with 10 mg of plasmid DNA using the calcium phosphate technique. The cells were then kept in culture for 14 days, changing the culture medium every 3 days. After this time the medium was removed and the cells stained with Leishmann's solution (Merck).
Cell lines expressing each mutant MT were isolated by cotransfecting 5 mg mutant DNA into Rat2 cell on a 5 cm petri dish together with 1 mg of the plasmid pSV2neo. Twenty-four hours after transfection, the cells were subcultured into media containing 700 mg/ml of G418 (Life Technologies). After 7 days, individual colonies were isolated, checked by Western blotting for MT synthesis, and then re-cloned by limiting dilution.
